ASRV vs JPM
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
ASRV's Piotroski F-Score of 2/9 indicates weak financial health, signaling significant concerns in operational efficiency and profitability sustainability. The absence of an Altman Z-Score raises red flags regarding bankruptcy risk, especially given the company's low ROE (4.95%) and minimal cash reserves. While the stock trades at a deep discount to its Graham Number ($7.43) and intrinsic value ($10.03), suggesting strong undervaluation, this is offset by poor financial health metrics and a bearish technical trend. The company exhibits impressive earnings growth (74.8% YoY) and strong historical EPS surprises, but these gains are not supported by robust balance sheet strength or consistent profitability. Overall, the stock presents a speculative opportunity with high risk.
JPM shows bullish fundamentals based on deterministic rules. Financial strength is weak (F-Score 2/9). Key strengths include strong valuation and growth metrics. Price trades at a 109.8% premium to fair value estimate ($140.21), limiting near-term upside from a valuation perspective.
Compare Another Pair
Related Comparisons
ASRV vs JPM: Head-to-Head Comparison
This page compares AmeriServ Financial, Inc. (ASRV) and JPMorgan Chase & Co. (JPM) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.